Pharmaceuticals: Novo Nordisk's Wegovy Outlook Strong
Pharmaceutical giant Novo Nordisk (NVO) is poised for a significant milestone as its CEO confirms that FDA approval for the high-dose version of its popular weight-loss drug, Wegovy, remains on track for the first quarter of 2026. This comes on the heels of positive early signs from the high-dose Wegovy launch in the UK, suggesting strong international demand for the treatment. The anticipated approval could further solidify Novo Nordisk's position in the rapidly expanding obesity management market.
Currency Markets: Yen Extends Decline Against US Dollar
The Japanese Yen continues its downward trend against the US Dollar, with the currency last reported down 0.6% to trade at 156.67. This movement extends the Yen's recent depreciation, with the USD/JPY exchange rate rising to 156.4610 on February 4, 2026, marking a 0.44% increase from the previous session. Ongoing currency market volatility and differing monetary policy outlooks between the US and Japan are contributing factors to the Yen's weakness.
US Policy: Senators Push $70 Billion for Critical Minerals
US Senators are reportedly pushing a $70 billion funding deal to support Donald Trump’s critical minerals agenda, according to the Financial Times. This substantial investment aims to reduce US dependence on foreign sources for essential materials like gallium, cobalt, lithium, and rare earth elements, which are crucial for various industries including technology, defense, and electric vehicles. The initiative is designed to bolster domestic supply chains and national security.
Global Energy: Kremlin Acknowledges India's Oil Diversification
The Kremlin has stated its awareness that Russia is not the only supplier of oil, in response to inquiries regarding India's plans to diversify its oil supplies. India, a significant buyer of discounted Russian oil in recent years, has been actively seeking to broaden its energy import sources. This development underscores the evolving dynamics in global energy markets and India's strategic efforts to secure its energy needs.
Eurozone Economy: Italy's January Inflation Data
Italy's Consumer Price Index (CPI) EU Harmonized (Y/Y) for January's preliminary reading registered 1.0%, slightly above the estimated 0.8% but a decrease from the previous month's 1.2%. The month-over-month (M/M) EU Harmonized CPI showed a -1.0% change, largely in line with estimates. Meanwhile, CPI NIC Including Tobacco (Y/Y) was also 1.0%, surpassing the 0.9% estimate. These figures suggest that while inflation in Italy remains present, it is showing signs of moderation.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.